US Patent Issued to Ultragenyx Pharmaceutical, Kyowa Kirin on July 15 for "Methods for increasing serum concentration of phosphorous and/or 1,25-hydroxy vitamin d" (American, Japanese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,976, issued on July 15, was assigned to Ultragenyx Pharmaceutical Inc. (Novato, Calif.) and Kyowa Kirin Co. Ltd. (Tokyo).

"Methods for increasing serum concentration of phosphorous and/or 1,25-hydroxy vitamin d" was invented by Emil D. Kakkis (Novato, Calif.), Javier San Martin (Novato, Calif.) and Tomohiro Sudo (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compositions and methods for treating a hypophosphatemic disorder, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition containing an anti-FGF23 ligand, wherein the dosing regimen of the pharmace...